Verastem, Inc.Equity-NMS: VSTM
Equity-NMS: VSTM
$13.02
+0.56
(3 Mar)
Loading Chart
1D
1W
3M
1Y
5Y
Previous close
$13.02
Open
$13.02
Today’s high
$13.61
Today’s low
$12.46
52W low
$4.20
52W high
$15.18
1Y
121.43%
5Y
-18.92%
Shares O/S
25.30M
Market cap
329.41M
Insights
VSTM price is below its 200 day moving average
VSTM PE is in the top end of its range over the past 2 years
VSTM is in the highest 10% returns in the past year. It is a high momentum stock. High momentum stocks tend to outperform in the near term.
In beta. Send feedback here.
Compare with other stock
Price
1D
PE
Market cap
About Verastem, Inc.

Verastem, Inc. is a late-stage development biopharmaceutical company. The Company’s pipeline is focused on anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly rapidly accelerated fibrosarcoma (RAF)/mitogen-activated protein kinase kinase (MEK) inhibition and focal adhesion kinase (FAK) inhibition.

The Company’s advanced product candidates, Avutometinib (VS-6766) and Defactinib, are being investigated in both preclinical and clinical studies for the treatment of various solid tumors, including, but not limited to low-grade serous ovarian cancer (LGSOC), non-small cell lung cancer (NSCLC), colorectal cancer (CRC), pancreatic cancer, and melanoma. VS-6766 is an orally available small molecule RAF/MEK clamp. Defactinib is an oral small molecule inhibitor of FAK and proline-rich tyrosine kinase (PYK2) that is being evaluated as a potential combination therapy for various solid tumors. .


FAQs

Can I buy Verastem, Inc. shares in India?
How to buy Verastem, Inc. shares in India?
What is the share price of Verastem, Inc.?
What is the Market Capitalization of Verastem, Inc.?
What is the PE ratio of Verastem, Inc.?
Is Verastem, Inc. a good stock to buy?
In which sector / industry does Verastem, Inc. operate?